Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

OpGen, Inc.

OPGNNASDAQ
Healthcare
Medical - Diagnostics & Research
$31.75
$7.77(32.40%)
U.S. Market opens in 17h 10m

OpGen, Inc. Fundamental Analysis

OpGen, Inc. (OPGN) shows strong financial fundamentals with a PE ratio of 35.14, profit margin of 76.04%, and ROE of 77.64%. The company generates $0.0B in annual revenue with strong year-over-year growth of 52.02%.

Key Strengths

ROE77.64%
Operating Margin73.10%
PEG Ratio-0.51
Current Ratio7.06

Areas of Concern

Cash Position0.18%
We analyze OPGN's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 81.1/100 based on profitability, valuation, growth, and balance sheet metrics. The B+ grade reflects solid fundamentals with room for improvement in valuation or growth.

Fundamental Health Score

B+
81.1/100

We analyze OPGN's fundamental strength across five key dimensions:

Efficiency Score

Excellent

OPGN demonstrates superior asset utilization.

ROA > 10%
54.14%

Valuation Score

Moderate

OPGN shows balanced valuation metrics.

PE < 25
35.14
PEG Ratio < 2
-0.51

Growth Score

Moderate

OPGN shows steady but slowing expansion.

Revenue Growth > 5%
52.02%
EPS Growth > 10%
1.06%

Financial Health Score

Excellent

OPGN maintains a strong and stable balance sheet.

Debt/Equity < 1
0.37
Current Ratio > 1
7.06

Profitability Score

Moderate

OPGN maintains healthy but balanced margins.

ROE > 15%
77.64%
Net Margin ≥ 15%
76.04%
Positive Free Cash Flow
No

Key Financial Metrics

Is OPGN Expensive or Cheap?

P/E Ratio

OPGN trades at 35.14 times earnings. This suggests a premium valuation.

35.14

PEG Ratio

When adjusting for growth, OPGN's PEG of -0.51 indicates potential undervaluation.

-0.51

Price to Book

The market values OpGen, Inc. at 23.67 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

23.67

EV/EBITDA

Enterprise value stands at 33.11 times EBITDA. This signals the market has high growth expectations.

33.11

How Well Does OPGN Make Money?

Net Profit Margin

For every $100 in sales, OpGen, Inc. keeps $76.04 as profit after all expenses.

76.04%

Operating Margin

Core operations generate 73.10 in profit for every $100 in revenue, before interest and taxes.

73.10%

ROE

Management delivers $77.64 in profit for every $100 of shareholder equity.

77.64%

ROA

OpGen, Inc. generates $54.14 in profit for every $100 in assets, demonstrating efficient asset deployment.

54.14%

Following the Money - Real Cash Generation

Operating Cash Flow

OpGen, Inc. generates limited operating cash flow of $-1.22M, signaling weaker underlying cash strength.

$-1.22M

Free Cash Flow

OpGen, Inc. generates weak or negative free cash flow of $-1.22M, restricting financial flexibility.

$-1.22M

FCF Per Share

Each share generates $-0.12 in free cash annually.

$-0.12

FCF Yield

OPGN converts -0.50% of its market value into free cash.

-0.50%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

35.14

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.51

vs 25 benchmark

P/B Ratio

Price to book value ratio

23.67

vs 25 benchmark

P/S Ratio

Price to sales ratio

26.92

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.37

vs 25 benchmark

Current Ratio

Current assets to current liabilities

7.06

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.78

vs 25 benchmark

ROA

Return on assets percentage

0.54

vs 25 benchmark

ROCE

Return on capital employed

0.55

vs 25 benchmark

How OPGN Stacks Against Its Sector Peers

MetricOPGN ValueSector AveragePerformance
P/E Ratio35.1429.43 Worse (Expensive)
ROE77.64%800.00% Weak
Net Margin76.04%-20145.00% (disorted) Strong
Debt/Equity0.370.30 Weak (High Leverage)
Current Ratio7.064.64 Strong Liquidity
ROA54.14%-17936.00% (disorted) Strong

OPGN outperforms its industry in 3 out of 6 key metrics, particularly excelling in Net Margin, but lagging in P/E Ratio.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews OpGen, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

-97.42%

Industry Style: Defensive, Growth, Innovation

Declining

EPS CAGR

101.67%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

99.26%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ